Pulmonary Hypertension: Beyond the Swan Ganz Catheter

References• Barnett, C. F., Hsue, P. Y., Machado, R. F. (2008). Pulmonary hypertension: An increasinglyrecognized complication of hereditary hemolytic anemias and HIV infection. Journal of theAmerican Medical Association, 299(3), pp. 324‐331.• Brenot, F., Herve, P., Petitpretz, P., Parent, F., Duroux, P., Simonneau, G. (1993). Primarypulmonary hypertension and fenfluramine use. British Heart Journal, 70(6), pp. 537‐541.• Butler, J., Stankewicz, M. A., Wu, J., Chomsky, D. B., Howser, R. L, Khadim, G. et al. (2005). Pretransplantreversible pulmonary hypertension predicts higher risk for mortality after cardiactransplantation. Journal of Heart and Lung Transplantation, 24(2), pp. 170‐177.• Cheever, K. H. (2005). An overview of pulmonary arterial hypertension: Risks, pathogenesis,clinical manifestations and management. Journal of Cardiovascular Nursing, 20(2), pp. 108‐116.• Chin, K. M., Channick, R. N. & Rubin, U. (2006). Is methamphetamine use associated withidiopathic pulmonary arterial hypertension? Chest, 130(6), pp. 1657‐1663.• Dorfmuller, P., Humbert, M., Perros, F., Sanchez, O., Simonneau, G., Muller, K. M. (2007). Fibrousremodeling of the pulmonary venous system in pulmonary arterial hypertension associated withconnective tissue diseases. Human Pathology, 38(6), pp. 893‐902.• Enriquez‐Sarano, M., Rossi, A., Seward, J. B., Bailey, K. R. & Tajik, A. J. (1997). Determinants ofpulmonary hypertension in left ventricular dysfunction. Journal of the American College ofCardiology, 29(1), pp. 153‐159.• Hargett, C. W. & Tapson, V. F. (2005). Brain natriuretic peptide: diagnostic and therapeuticimplications in pulmonary arterial hypertension. Seminars in R espiratory and Critical CareMedicine, 26(4), pp. 385‐393.